Advisory Board

The LSM advisory board is designed to bring together industry leaders, scientific and medical experts, and corporate executives who can provide guidance and feedback on both curricular and co-curricular aspects of the program.
 

Current members of the advisory board are:

Ron Belldegrun 

(C'08)
CEO, Co-Founder
ByHeart

Adam Koppel, M.D. Ph.D.

(MED'95, GR'97, WG'00)
Managing Director, Biosciences
Bain Capital

Robert Benz, M.D.

(C'74, PAR'05, PAR'06)
Vice President of Medical Affairs
Lankenau Medical Center
Chief of Nephrology
Main Line Health Hospital

 

Ameet Mallik

(WG'00)
President and CEO
ADC Therapeutics

Laura Bessen, M.D.

Vice President, Head of U.S. Medical (retired)
Bristol-Myers Squibb

Bill Martin, Ph.D.

Senior Vice President, Global Neuroscience Therapeutic Area Head
Johnson & Johnson Innovative Medicine

David Blumberg

(WG'90): Advisory Board Chair
Retired Principal and Advisory Sector Leader - Pharmaceuticals 
KPMG LLP
VP Global Commercial Compliance - 
Teva Pharmaceuticals

Vijai Mohan

(C'98, GR'99)
CEO
Marguron Pharmaceuticals, Inc

Ellen Davis

(W'85, PAR'13)

Member, Board of Overseers 
Weill Cornell Medicine
Member, Board of Overseers 
Melanoma Research Alliance

Phil Ross, M.D.

Global Chairman, Investment Banking
J.P. Morgan

Garret FitzGerald, M.D.

Professor of Medicine and Chair, Department of Pharmacology
University of Pennsylvania

Lee Schalop, M.D

(C'85, W'85)
Biotech Industry Angel Investor and Entrepreneur

David Gluckman, M.D.

(WG'98)
Vice Chairman of Investment Banking
Global Head of Healthcare
Lazard, LLC

Barbara Schilberg, J.D.

Managing Director & Chief Executive Officer (retired)
BioAdvance

Henry Gosebruch

(W'95)
President and CEO
Neumora

Lisa Schoenberg

(W'93)
Vice President, Sales & Marketing (retired)
AstraZeneca 

Keith Gottesdiener, M.D.

(MED'82)
President & CEO
Prime Medicine, Inc

Sheri Schully, Ph.D.

Deputy Chief Medical and Scientific Officer, All of Us Research Program
National Institutes of Health

Evis Hursever, Ph.D.

(GR'03)
Managing Director
EW Healthcare Partners

Martin Silverstein, M.D.

(C'76, PAR'11)
Special Advisor
Mana Therapeutics

Najat Khan, Ph.D.

Chief Data Science Officer, Global Head, Strategy & Operations
Janssen Research & Development

Richard L. Solit, M.D.

Portfolio Manager
Adage Capital Management

Lorence Kim, M.D.

(MED'99, WG'99)
Co-Founder and Managing Partner
Ascenta Capital

Kuo Tong

(C'89) 
Managing Director (Retired)
Guidehouse/ Navigant Consulting

Brian Kim

(C'93, W'93)
Founder, CEO, Executive Director
Fortis Life Sciences

P. Roy Vagelos, M.D. 

(C'50) - honorary member
Chairman of the Board
Regeneron Pharmaceuticals, Inc.
Retired Chair of the Board and Chief Executive Officer
Merck 

 

 

Alumni members of the advisory board are:

Pia Banerjee

LSM'10

Executive Director, 

Head of Investor Relations and Strategy

Arcus Biosciences

Nicholas Wilcox, M.D.

LSM'13

Resident Physician, Internal Medicine

Penn Medicine